14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.22 $14.43 Friday, 3rd May 2024 BMEA stock ended at $12.35. This is 3.52% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.57% from a day low at $12.19 to a day high of $13.11.
90 days $10.22 $19.89
52 weeks $8.13 $43.64

Historical Biomea Fusion, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $12.83 $13.11 $12.19 $12.35 680 666
May 02, 2024 $11.53 $12.07 $11.40 $11.93 758 558
May 01, 2024 $10.72 $12.08 $10.60 $11.57 1 114 093
Apr 30, 2024 $10.66 $11.13 $10.56 $10.74 581 865
Apr 29, 2024 $10.86 $11.16 $10.62 $10.75 509 790
Apr 26, 2024 $10.57 $10.90 $10.40 $10.78 581 643
Apr 25, 2024 $10.53 $10.55 $10.26 $10.47 497 668
Apr 24, 2024 $11.00 $11.24 $10.45 $10.77 751 203
Apr 23, 2024 $10.79 $11.39 $10.72 $10.98 685 328
Apr 22, 2024 $11.01 $11.28 $10.81 $10.83 594 692
Apr 19, 2024 $11.03 $11.55 $10.22 $10.85 1 313 228
Apr 18, 2024 $11.41 $11.87 $10.95 $11.16 1 668 489
Apr 17, 2024 $12.09 $12.10 $11.44 $11.50 695 684
Apr 16, 2024 $12.40 $12.58 $11.81 $11.95 614 085
Apr 15, 2024 $12.88 $13.37 $12.11 $12.51 706 127
Apr 12, 2024 $13.23 $13.66 $12.64 $12.98 1 027 293
Apr 11, 2024 $12.82 $13.43 $12.56 $13.28 780 194
Apr 10, 2024 $12.31 $12.88 $12.30 $12.76 786 663
Apr 09, 2024 $12.51 $12.87 $12.20 $12.80 855 945
Apr 08, 2024 $12.77 $12.98 $12.43 $12.51 583 002
Apr 05, 2024 $12.61 $13.28 $12.01 $12.73 1 218 062
Apr 04, 2024 $14.03 $14.43 $12.52 $12.61 1 242 057
Apr 03, 2024 $13.00 $13.98 $13.00 $13.96 1 380 454
Apr 02, 2024 $13.78 $14.00 $12.58 $12.80 2 806 851
Apr 01, 2024 $15.35 $16.29 $14.42 $15.30 1 442 235
Click to get the best stock tips daily for free!

About Biomea Fusion, Inc.

Biomea Fusion. Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in R... BMEA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT